Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

Market Cap	2.56B -10.2%
Revenue (ttm)	843.87M -20.6%
Net Income	49.37M +129.2%
EPS	0.16 +129.1%
Shares Out	303.35M
PE Ratio	51.85
Forward PE	n/a
Dividend	0.04 (0.46%)
Ex-Dividend Date	May 22, 2026

Volume	4,811,100
Average Volume	6,134,888
Open	8.80
Previous Close	8.69
Day's Range	8.42 - 8.83
52-Week Range	8.43 - 12.90
Beta	0.53
RSI	28.55
Earnings Date	Aug 21, 2026

About SHE:300534

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and is based in Lanzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 641
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300534

Financial Performance

In 2025, SHE:300534's revenue was 886.96 million, a decrease of -14.92% compared to the previous year's 1.04 billion. Earnings were 43.95 million, an increase of 79.56%.